| Literature DB >> 34094439 |
Yidong Wang1, Jin Zhu1, Rui Guo1, Haley Lindberg1, Yi-Ming Wang1.
Abstract
The deprotonation of propargylic C-H bonds for subsequent functionalization typically requires stoichiometric metal alkyl orEntities:
Year: 2020 PMID: 34094439 PMCID: PMC8163013 DOI: 10.1039/d0sc05091a
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Scheme 1Complexation-assisted deprotonation as an underexplored mode of propargylic activation.
Fig. 1Natural products and bioactive compounds containing tetrahydroisoquinoline, piperidine, or dihydroisochroman ring systems.
Optimization of reaction conditionsa
|
| ||||
|---|---|---|---|---|
| Entry | CpR | Base | Solvent | Yield |
| 1 | Cp* | TMPH | DCE | 31 |
| 2 | Cp* | PMP | DCE | Trace |
| 3 | Cp* | i-Pr2NEt | DCE | Trace |
| 4 | Cp* | Pyridine | DCE | 0 |
| 5 | Cp* | 2,6-Lutidine | DCE | 34 |
| 6 | Cp* |
| DCE | 62 |
| 7 | Cp |
| DCE | 10 |
| 8 | CpR1 |
| DCE | 14 |
| 9 | CpR2 |
| DCE | 20 |
| 10 | Cp* |
| CHCl3 | 60 |
| 11 | Cp* |
| PhCl | 70 |
| 12 | Cp* |
| PhCF3 | 83 |
| 13 | Cp* |
| PhCF3 | 77 (72 |
| 14 | Cp* |
| PhCF3 | 56 |
All reactions were carried out with 1a (0.1 mmol), 2a (1.5 equiv.), Ph3C+BF4− (1.7 equiv.), base (1.8 equiv.) and 30 mol% of iron catalyst in solvent (0.5 mL).
NMR yield.
20 mol% of iron catalyst.
Isolated yield.
10 mol% iron catalyst. DCE = 1,2-dichloroethane. PMP = 1,2,2,6,6-pentamethylpiperidine. sym-Collidine = 2,4,6-collidine. Cp* = pentamethylcyclopentadienyl. CpR1 = 1,3-(t-Bu)2cyclopentadienyl, CpR2 = tetramethylcyclopentadienyl.
Scheme 2Substrate scope for the catalytic C–H propargylic functionalization to form alkylation products 3: standard conditions: 1 (0.30 mmol), 2 (1.5 equiv.), Ph3C+BF4− (1.7 equiv.), sym-collidine (1.8 equiv.), [Cp*Fe(CO)2(thf)]+BF4− (20 mol%), PhCF3 (0.2 M), 60 °C, 48 h. CHCl3 (0.2 M) was used as the solvent. NPhth = phthalimide. Fmoc = fluorenylmethyloxycarbonyl.
Scheme 3Substrate scope for the coupling of olefins with 2a. Standard conditions: 4 (0.3 mmol), 2a (1.5 equiv.), Ph3C+BF4− (1.7 equiv.), sym-collidine (1.8 equiv.), [Cp*Fe(CO)2(thf)]+BF4− (20 mol%), PhCF3 (0.2 M), 60 °C, 48 h. CpR1Fe(CO)2(thf)BF4 (20 mol%) was used as the iron catalyst, PhCF3 (0.3 M). CpR1 = 1,3-(t-Bu)2cyclopentadienyl.
Scheme 4Stoichiometric NMR experiments using [CpFe(CO)2(3-hexyne)]+BF4− and [Cp*Fe(CO)2(3-hexyne)]+BF4− .
Fig. 2NMR study of functionalization with Cp* as the supporting ligand.
Fig. 3NMR study of functionalization and alkyne exchange with Cp* as the supporting ligand.
Scheme 5Regioselectivity studies. Standard conditions: 1 (0.30 mmol), Ph3C+BF4− (1.5 equiv.), sym-collidine (1.5 equiv.), [Cp*Fe(CO)2(thf)]+BF4− (10 mol%), DCE (0.5 M), 60 °C, 48 h. NPhth = phthalimide.